Covicept commences Phase II oral Covid-19 drug trial in Brazil
The trial will analyse the safety and efficacy of PSJ-539 in newly diagnosed Covid-19 patients.
South & Central America
Latest in
South & Central America
Kintor receives approval for Covid-19 trial of proxalutamide in Brazil
The multi-regional trial will evaluate the efficacy and safety of the therapy in 1,030 hospitalised Covid-19 patients.
Appili concludes subject enrolment in Phase III Covid-19 drug trial
In November 2020, Appili commenced the trial for evaluating oral Avigan/Reeqonus as a potential at-home treatment for Covid-19.
Inovio to commence Phase III trial of Covid-19 vaccine in Mexico
The trial will evaluate the efficacy of a two-dose regimen of INO-4800 administered one month apart in adult subjects.
HDT Bio and SENAI CIMATEC get approval to trial Covid-19 vaccine in Brazil
SENAI CIMATEC licensed HDT Bio’s technology to carry out research, production and marketing of HDT-301 in Brazil.
Inovio to initiate Phase III trial of Covid-19 DNA vaccine in Brazil
The Phase III trial initiation follows regulatory approval from Brazilian ANVISA to conduct the study.
EOM Pharmaceuticals doses first subjects in Phase I/IIa Covid-19 drug trial
The trial will evaluate the safety, tolerability and preliminary efficacy of EOM613 in approximately 40 subjects in Brazil.
CytoDyn receives Brazilian ANVISA’s approval for Phase III Covid-19 trial
The trial will have 612 hospitalised Covid-19 patients who need oxygen support enrolled at up to 35 centres in Brazil.